Ads
related to: treating executive dysfunction in adults adhd
Search results
Results From The WOW.Com Content Network
In both children and adults with ADHD, an underlying executive dysfunction involving the prefrontal regions and other interconnected subcortical structures has been found. [55] As a result, people with ADHD commonly perform more poorly than matched controls on interference control, mental flexibility and verbal fluency.
Attention deficit hyperactivity disorder (ADHD) [1] is a neurodevelopmental disorder characterized by executive dysfunction occasioning symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and developmentally-inappropriate. [9]
In this episode of The Conversation Weekly podcast, we explore what adult ADHD looks like, how it is diagnosed today and the many new treatments available to help those with the disorder live ...
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
That’s what executive dysfunction is: a disruption to certain brain processes that help us remember what we’re doing in the moment and control our thoughts, emotions, and behavior.
Males with ADHD, children, and adults exhibit higher rates of externalizing disorders or behaviors that manifest as aggressive, disruptive, rule-breaking behaviors, making them more likely to be referred for ADHD treatment. Adult males with ADHD are also more likely to display antisocial behaviors associated with antisocial personality disorder ...
A fairly recent focus has been placed on understanding the impact Attention deficit hyperactivity disorder has on individuals’ executive processes. People with ADHD share several similar behavioural manifestations with patients confirmed with disruption to executive functions, characteristic of SAS deficiencies.
Atomoxetine, formerly sold under the brand name Strattera [12], is a selective norepinephrine reuptake inhibitor (sNRI) medication used to treat attention deficit hyperactivity disorder (ADHD) [13] and, to a lesser extent, cognitive disengagement syndrome (CDS). [14] [15] [16] It may be used alone or along with stimulant medication.